Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 11, 2017 - Issue
Submit an article Journal homepage
167
Views
25
CrossRef citations to date
0
Altmetric
Review

New developments in the management of partial-onset epilepsy: role of brivaracetam

Giangennaro Coppola1 Unit of Child and Adolescent Neuropsychiatry, Department of Medicine and Surgery, University of Salerno, SalernoCorrespondence[email protected]
,
Giulia Iapadre2 Department of Pediatrics, University of L’Aquila, L’Aquila, Italy
,
Francesca Felicia Operto1 Unit of Child and Adolescent Neuropsychiatry, Department of Medicine and Surgery, University of Salerno, Salerno
&
Alberto Verrotti2 Department of Pediatrics, University of L’Aquila, L’Aquila, Italy
Pages 643-657 | Published online: 06 Mar 2017

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Giulia Liparoti, Beatrice Burchiani, Elisabetta Mencaroni, Domenico Tripodi, Giuseppe Di Cara & Alberto Verrotti. (2022) Individualizing doses of antiepileptic drugs. Expert Opinion on Drug Metabolism & Toxicology 18:3, pages 219-233.
Read now
Eleonora Tulli, Giuseppe Di Cara, Giulia Iapadre, Pasquale Striano & Alberto Verrotti. (2021) An update on brivaracetam for the treatment of pediatric partial epilepsy. Expert Opinion on Pharmacotherapy 22:11, pages 1387-1395.
Read now
Anteneh M Feyissa. (2019) Brivaracetam in the treatment of epilepsy: a review of clinical trial data. Neuropsychiatric Disease and Treatment 15, pages 2587-2600.
Read now
Stefano de Biase, Annacarmen Nilo, Andrea Bernardini, Gian Luigi Gigli, Mariarosaria Valente & Giovanni Merlino. (2019) Timing use of novel anti-epileptic drugs: is earlier better?. Expert Review of Neurotherapeutics 19:10, pages 945-954.
Read now
Jasmina R. Milovanović, Slobodan M. Janković, Ana Pejčić, Miloš Milosavljević, Valentina Opančina, Vesela Radonjić, Zoran Protrka & Marina Kostić. (2017) Evaluation of brivaracetam: a new drug to treat epilepsy. Expert Opinion on Pharmacotherapy 18:13, pages 1381-1389.
Read now

Articles from other publishers (20)

Micheal Strein, John P. Holton‐Burke, Spiro Stilianoudakis, Carley Moses, Sulaiman Almohaish & Gretchen M. Brophy. (2023) Levetiracetam‐associated behavioral adverse events in neurocritical care patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43:2, pages 122-128.
Crossref
Sophie Naddell, Megan Manuel, Rebecca Cavill, Paul White & Katarzyna Sieradzan. (2023) BRIVEST: A ‘real-world’ observational, single-centre study investigating the efficacy, safety and tolerability of Brivaracetam. Epilepsy & Behavior 138, pages 108985.
Crossref
Angelo Russo, Jacopo Pruccoli, Carlo Alberto Cesaroni, Laura Maria Beatrice Belotti, Corrado Zenesini, Paolo Bonanni, Antonella Boni, Elisabetta Cesaroni, Giangennaro Coppola, Duccio Maria Cordelli, Alberto Danieli, Maria Margherita Mancardi, Francesca Marchese, Sara Matricardi, Tullio Messana, Giovanna Martina Nocera, Francesca Felicia Operto, Giuditta Pellino, Federica Reina, Francesca Vanadia, Alberto Verrotti & Pasquale Striano. (2022) Brivaracetam add-on treatment in pediatric patients with severe drug-resistant epilepsy: Italian real-world evidence. Seizure 102, pages 120-124.
Crossref
Chantal Depondt, Wim Van Paesschen, Kenou van Rijckevorsel, Iryna Leunikava & France Ferrière. (2021) Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review. Drugs - Real World Outcomes 8:3, pages 407-415.
Crossref
Gajanan Vithoba Panchal & Vijay Nath Mishra. (2021) A brief review on efficacy and safety of brivaracetam in the management of partial onset epilepsy. IP Indian Journal of Neurosciences 7:2, pages 99-105.
Crossref
Kumar Sannagowdara & Nadir Khan. (2021) Medical Management in Focal versus Generalized Epilepsy. Journal of Pediatric Epilepsy 10:02, pages 081-087.
Crossref
Francesca Felicia Operto, Grazia Maria Giovanna Pastorino, Carlo Di Bonaventura, Chiara Scuoppo, Chiara Padovano, Valentina Vivenzio, Serena Donadio & Giangennaro Coppola. (2021) Effects of antiseizure monotherapy on visuospatial memory in pediatric age. European Journal of Paediatric Neurology 32, pages 106-114.
Crossref
Te-Yu Hung, Sheng-Nan Wu & Chin-Wei Huang. (2021) The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability. Biomedicines 9:4, pages 369.
Crossref
Alberto Verrotti, Eleonora A. Grasso, Marta Cacciatore, Sara Matricardi & Pasquale Striano. (2020) Potential role of brivaracetam in pediatric epilepsy. Acta Neurologica Scandinavica 143:1, pages 19-26.
Crossref
Vijayakumar Baksam, Saritha N, Vasundara Reddy Pocha, Veera Babu Chakka, Ravindra Reddy Ummadi & Pramod Kumar. (2020) Development of an effective novel validated stability‐indicating HPLC method for the resolution of brivaracetam stereoisomeric impurities. Chirality 32:9, pages 1208-1219.
Crossref
Gashirai K Mbizvo, Bharath Chandrasekar, Sarah J Nevitt, Pete Dixon, Jane L Hutton & Anthony G Marson. (2020) Levetiracetam add-on for drug-resistant focal epilepsy. Cochrane Database of Systematic Reviews 2020:6.
Crossref
Klaus Rose, David Neubauer & Jane M. Grant-Kels. (2019) Questionable Industry-Sponsored Postneonatal Pediatric Studies in Slovenia. Current Therapeutic Research 90, pages 86-91.
Crossref
Giulia Iapadre, Ganna Balagura, Luca Zagaroli, Pasquale Striano & Alberto Verrotti. (2018) Pharmacokinetics and Drug Interaction of Antiepileptic Drugs in Children and Adolescents. Pediatric Drugs 20:5, pages 429-453.
Crossref
Clare E. Stevens & Carl E. Stafstrom. (2018) Pharmacotherapy for Focal Seizures in Children and Adolescents. Drugs 78:13, pages 1321-1337.
Crossref
Alexis Arzimanoglou, O’Neill D’Cruz, Douglas Nordli, Shlomo Shinnar & Gregory L. Holmes. (2018) A Review of the New Antiepileptic Drugs for Focal-Onset Seizures in Pediatrics: Role of Extrapolation. Pediatric Drugs 20:3, pages 249-264.
Crossref
Christine S. Fuchs, Judith E. Farnberger, Georg Steinkellner, Johann H. Sattler, Mathias Pickl, Robert C. Simon, Ferdinand Zepeck, Karl Gruber & Wolfgang Kroutil. (2018) Asymmetric Amination of α-Chiral Aliphatic Aldehydes via Dynamic Kinetic Resolution to Access Stereocomplementary Brivaracetam and Pregabalin Precursors . Advanced Synthesis & Catalysis 360:4, pages 768-778.
Crossref
Zhu Li-na, Chen Deng, Wang Hai-jiao, Xu Da, Tan Ge & Liu Ling. (2018) Indirect comparison of third-generation antiepileptic drugs as adjunctive treatment for uncontrolled focal epilepsy. Epilepsy Research 139, pages 60-72.
Crossref
Nicholas G. Avgeropoulos & Herbert B. Newton. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 21 44 .
Jorge Vidaurre, Satyanarayana Gedela & Shannon Yarosz. (2017) Antiepileptic Drugs and Liver Disease. Pediatric Neurology 77, pages 23-36.
Crossref
V. I. Guzeva, I. V. Okhrim, O. V. Guzeva, V. V. Guzeva & N. E. Maksimova. (2017) New opportunities in the optimization of epilepsy treatment in adolescents. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 117:9, pages 70.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.